Prostate cancer Board decisions

The Board has decided to remand the case due to insufficient medical opinions regarding the cause and aggravation of sleep apnea, specifically in relation to service-connected hypertension and prostate cancer.

The Board has granted service connection for prostate cancer, lower urinary tract symptoms with incomplete emptying of the bladder, and skin cancer. The Veteran's prostate cancer is related to his participation in a Toxic Exposure Risk Activity (TERA) during service. His LUTS are secondary to his now service-connected prostate cancer. His skin cancer is linked to his exposure to sunlight during service.

The Veteran's claims for prostate cancer, an acquired psychiatric disorder, tremors, and neurological deficit in the legs are being remanded due to a pre-decisional duty to assist error. The TERA memo needs to be updated to consider all potential toxic exposures related to his MOS of Landing Support Specialist. A VA examination is needed to determine if these conditions are related to service, including any Camp Lejeune exposure.

The Board denied service connection for bladder and prostate cancer, finding that the cancers were not incurred in or related to service. The evidence did not support a direct link between the cancers and active duty.

The Veteran's service-connected disabilities, including prostate cancer, sleep apnea, and bilateral frostbite, have rendered him unable to secure or maintain substantially gainful employment since September 9, 2015. The Board has granted a TDIU effective that date.

The Board has decided to remand the case due to conflicting evidence regarding the nature of the Veteran's prostate condition and a need for further examination.

The Veteran's cause of death is remanded due to insufficient evidence regarding the relationship between his service-connected conditions and his death. The Board requests a medical opinion on the nature and etiology of the Veteran's cause of death.

The Board has decided to remand the case due to insufficient medical opinions regarding the cause of prostate cancer, specifically whether it is related to TERA exposure as an Aircraft Mechanic.

The appeal for an earlier effective date for service connection of diabetes mellitus type II is dismissed. The Veteran's claim for prostate cancer was granted with a noncompensable rating effective August 10, 2022, and the Board denied any request for an earlier effective date.

The Veteran's service-connected disabilities, including PTSD, ischemic heart disease, diabetic neuropathy, prostate cancer residuals, bilateral diabetic peripheral neuropathy of the lower extremities (sciatic), and diabetes mellitus Type 2, combine to result in physical or mental impairment that renders him so helpless as to require regular aid and attendance of another person. However, the need for aid and attendance must be determined without considering nonservice-connected disabilities.

The Board has remanded the Veteran's claims for prostate cancer, obstructive sleep apnea, Parkinson's disease, left kidney cancer with residuals, coronary artery disease, and hypertension due to potential toxic exposure during service. The AOJ is instructed to properly address these issues by developing evidence regarding the Veteran's toxic exposures.

The Board has denied the Veteran's claim for service connection for prostate cancer, finding that there is no relationship between his current condition and in-service asbestos exposure.

The Veteran's appeal to the July 2024 rating decision, which granted a 100% rating for prostate cancer from May 4, 2012, and denied a compensable rating from August 1, 2014, is dismissed as it does not affect an initial determination.

The Board has granted service connection for prostate cancer, finding that the Veteran's exposure to herbicide agents during his active duty in Okinawa is presumed. The decision also acknowledges a private physician's opinion linking the Veteran's prostate cancer to Agent Orange exposure.

The Board has granted service connection for prostate cancer, finding that the Veteran's exposure to radiation during his military service is at least as likely as not related to his current condition.

The Veteran's prostate cancer and Parkinson's disease are granted service connection, but additional development is needed to verify his exposure to trichloroethylene (TCE) during military service.

The Veteran's TDIU was granted effective June 15, 2022, based on his service-connected disabilities. The effective date for the establishment of basic eligibility for DEA benefits is also June 15, 2022.

The Veteran's tinnitus and bilateral hearing loss are granted service connection as they are related to in-service noise exposure.,A rating of 60 percent is granted for urinary incontinence following prostatectomy, requiring absorbent materials changed more than four times per day.

The Veteran's prostate cancer was granted service connection effective October 22, 2021. The decision found that the claim for service connection had been pending since October 20, 2020.

The Board has decided to remand the case due to an inadequate opinion regarding whether the Veteran's prostate cancer was caused or aggravated by his service, specifically exposure at Camp Lejeune. The VA will need to obtain a new medical opinion to address these issues.